Loading...

Jagust, William

TitleMedical Scientist Sr Faculty
InstitutionLawrence Berkeley National Lab
DepartmentMolecular Biophys & Integ Bio
Address1 Cyclotron Road
Berkeley CA 94720
Phone510/486-5065
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Aging Brain, Cognition, and Dopamine
    NIH/NIA R01AG044292Sep 1, 2013 - May 31, 2018
    Role: Principal Investigator
    PET/CT Imaging System
    NIH/NCRR S10RR029564Jul 1, 2010 - Jun 30, 2011
    Role: Principal Investigator
    Neural and Biochemical Mechanisms of Cognitive Aging
    NIH/NIA R01AG034570Sep 15, 2009 - May 31, 2021
    Role: Principal Investigator
    Molecular and Functional Imaging of Age Related Cognitive Decline
    NIH/NIA R01AG027984Apr 15, 2007 - Feb 29, 2012
    Role: Principal Investigator
    Amyloid Imaging in Frontotemporal Dementia and Alzheimer's Disease
    NIH/NIA R01AG027859Mar 1, 2007 - Feb 28, 2011
    Role: Principal Investigator
    Effects of Chemotherapy on Brain Function
    NIH/NIA R01AG025303Sep 15, 2006 - Jun 30, 2014
    Role: Principal Investigator
    UC Davis Alzheimer's Disease Core Center
    NIH/NIA P30AG010129Sep 30, 1991 - Jun 30, 2021
    Role: Co-Principal Investigator
    ALCOHOL AND MEMORY--A PET STUDY
    NIH/NIAAA R01AA009042Sep 1, 1991 - Aug 31, 1996
    Role: Principal Investigator
    LONGITUDINAL SPECT AND PET STUDIES OF DEMENTIA
    NIH/NIA R01AG007793Jul 1, 1988 - Mar 31, 1998
    Role: Principal Investigator
    STUDY SECTION CHAIRMANS FUND (NIH)
    NIH/NIA U09AG005389Aug 15, 1984 - Jul 31, 2005
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Leal SL, Lockhart SN, Maass A, Bell RK, Jagust W. Subthreshold Amyloid Predicts Tau Deposition in Aging. J Neurosci. 2018 May 09; 38(19):4482-4489. PMID: 29686045.
      View in: PubMed
    2. Jack CR, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, Siemers E, Snyder HM, Sperling R. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018 Apr; 14(4):535-562. PMID: 29653606.
      View in: PubMed
    3. Mattsson N, Groot C, Jansen WJ, Landau S, Villemagne V, Engelborghs S, Mintun M, Lleo A, Molinuevo JL, Jagust W, Frisoni GB, Ivanoiu A, Chételat G, Resende de Oliveira C, Rodrigue KM, Kornhuber J, Wallin A, Klimkowicz-Mrowiec A, Kandimella R, Popp J, Aalten PP, Aarsland D, Alcolea D, Almdahl IS, Baldeiras I, van Buchem MA, Cavedo E, Chen K, Cohen AD, Förster S, Fortea J, Frederiksen KS, Freund-Levi Y, Gill KD, Gkatzima O, Grimmer T, Hampel H, Herukka SK, Johannsen P, van Laere K, de Leon M, Maier W, Marcusson J, Meulenbroek O, Møllergård HM, Morris JC, Mroczko B, Nordlund A, Prabhakar S, Peters O, Rami L, Rodríguez-Rodríguez E, Roe CM, Rüther E, Santana I, Schröder J, Seo SW, Soininen H, Spiru L, Stomrud E, Struyfs H, Teunissen CE, Verhey FRJ, Vos SJB, van Waalwijk van Doorn LJC, Waldemar G, Wallin ÅK, Wiltfang J, Vandenberghe R, Brooks DJ, Fladby T, Rowe CC, Drzezga A, Verbeek MM, Sarazin M, Wolk DA, Fleisher AS, Klunk WE, Na DL, Sánchez-Juan P, Lee DY, Nordberg A, Tsolaki M, Camus V, Rinne JO, Fagan AM, Zetterberg H, Blennow K, Rabinovici GD, Hansson O, van Berckel BNM, van der Flier WM, Scheltens P, Visser PJ, Ossenkoppele R. Prevalence of the apolipoprotein E e4 allele in amyloid ß positive subjects across the spectrum of Alzheimer's disease. Alzheimers Dement. 2018 Mar 27. PMID: 29601787.
      View in: PubMed
    4. Harrison TM, Maass A, Baker SL, Jagust W. Brain morphology, cognition, and ß-amyloid in older adults with superior memory performance. Neurobiol Aging. 2018 Jul; 67:162-170. PMID: 29665578.
      View in: PubMed
    5. Sescousse G, Ligneul R, van Holst RJ, Janssen LK, de Boer F, Janssen M, Berry AS, Jagust W, Cools R. Spontaneous eye blink rate and dopamine synthesis capacity: preliminary evidence for an absence of positive correlation. Eur J Neurosci. 2018 May; 47(9):1081-1086. PMID: 29514419.
      View in: PubMed
    6. Landau SM, Horng A, Jagust W. Memory decline accompanies subthreshold amyloid accumulation. Neurology. 2018 Apr 24; 90(17):e1452-e1460. PMID: 29572282.
      View in: PubMed
    7. Jagust W. Following the pathway to Alzheimer's disease. Nat Neurosci. 2018 Mar; 21(3):306-308. PMID: 29476126.
      View in: PubMed
    8. Santos-Santos MA, Rabinovici GD, Iaccarino L, Ayakta N, Tammewar G, Lobach I, Henry ML, Hubbard I, Mandelli ML, Spinelli E, Miller ZA, Pressman PS, O'Neil JP, Ghosh P, Lazaris A, Meyer M, Watson C, Yoon SJ, Rosen HJ, Grinberg L, Seeley WW, Miller BL, Jagust W, Gorno-Tempini ML. Rates of Amyloid Imaging Positivity in Patients With Primary Progressive Aphasia. JAMA Neurol. 2018 Mar 01; 75(3):342-352. PMID: 29309493.
      View in: PubMed
    9. Winer JR, Maass A, Pressman P, Stiver J, Schonhaut DR, Baker SL, Kramer J, Rabinovici GD, Jagust W. Associations Between Tau, ß-Amyloid, and Cognition in Parkinson Disease. JAMA Neurol. 2018 Feb 01; 75(2):227-235. PMID: 29228071.
      View in: PubMed
    10. Jansen WJ, Ossenkoppele R, Tijms BM, Fagan AM, Hansson O, Klunk WE, van der Flier WM, Villemagne VL, Frisoni GB, Fleisher AS, Lleó A, Mintun MA, Wallin A, Engelborghs S, Na DL, Chételat G, Molinuevo JL, Landau SM, Mattsson N, Kornhuber J, Sabri O, Rowe CC, Parnetti L, Popp J, Fladby T, Jagust W, Aalten P, Lee DY, Vandenberghe R, Resende de Oliveira C, Kapaki E, Froelich L, Ivanoiu A, Gabryelewicz T, Verbeek MM, Sanchez-Juan P, Hildebrandt H, Camus V, Zboch M, Brooks DJ, Drzezga A, Rinne JO, Newberg A, de Mendonça A, Sarazin M, Rabinovici GD, Madsen K, Kramberger MG, Nordberg A, Mok V, Mroczko B, Wolk DA, Meyer PT, Tsolaki M, Scheltens P, Verhey FRJ, Visser PJ. Association of Cerebral Amyloid-ß Aggregation With Cognitive Functioning in Persons Without Dementia. JAMA Psychiatry. 2018 Jan 01; 75(1):84-95. PMID: 29188296.
      View in: PubMed
    11. Arnemann KL, Stöber F, Narayan S, Rabinovici GD, Jagust W. Metabolic brain networks in aging and preclinical Alzheimer's disease. Neuroimage Clin. 2018; 17:987-999. PMID: 29527500.
      View in: PubMed
    12. La Joie R, Bejanin A, Fagan AM, Ayakta N, Baker SL, Bourakova V, Boxer AL, Cha J, Karydas A, Jerome G, Maass A, Mensing A, Miller ZA, O'Neil JP, Pham J, Rosen HJ, Tsai R, Visani AV, Miller BL, Jagust W, Rabinovici GD. Associations between [18F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample. Neurology. 2018 Jan 23; 90(4):e282-e290. PMID: 29282337.
      View in: PubMed
    13. Helfrich RF, Mander BA, Jagust W, Knight RT, Walker MP. Old Brains Come Uncoupled in Sleep: Slow Wave-Spindle Synchrony, Brain Atrophy, and Forgetting. Neuron. 2018 Jan 03; 97(1):221-230.e4. PMID: 29249289.
      View in: PubMed
    14. Bejanin A, Schonhaut DR, La Joie R, Kramer JH, Baker SL, Sosa N, Ayakta N, Cantwell A, Janabi M, Lauriola M, O'Neil JP, Gorno-Tempini ML, Miller ZA, Rosen HJ, Miller BL, Jagust W, Rabinovici GD. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease. Brain. 2017 Dec 01; 140(12):3286-3300. PMID: 29053874.
      View in: PubMed
    15. Ossenkoppele R, Jagust W. The Complexity of Subjective Cognitive Decline. JAMA Neurol. 2017 Dec 01; 74(12):1400-1402. PMID: 28973114.
      View in: PubMed
    16. Maass A, Lockhart SN, Harrison TM, Bell RK, Mellinger T, Swinnerton K, Baker SL, Rabinovici GD, Jagust W. Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging. J Neurosci. 2018 Jan 17; 38(3):530-543. PMID: 29192126.
      View in: PubMed
    17. Jang YK, Lyoo CH, Park S, Oh SJ, Cho H, Oh M, Ryu YH, Choi JY, Rabinovici GD, Kim HJ, Moon SH, Jang H, Lee JS, Jagust W, Na DL, Kim JS, Seo SW. Head to head comparison of [18F] AV-1451 and [18F] THK5351 for tau imaging in Alzheimer's disease and frontotemporal dementia. Eur J Nucl Med Mol Imaging. 2018 Mar; 45(3):432-442. PMID: 29143870.
      View in: PubMed
    18. Palmqvist S, Schöll M, Strandberg O, Mattsson N, Stomrud E, Zetterberg H, Blennow K, Landau S, Jagust W, Hansson O. Earliest accumulation of ß-amyloid occurs within the default-mode network and concurrently affects brain connectivity. Nat Commun. 2017 Oct 31; 8(1):1214. PMID: 29089479.
      View in: PubMed
    19. Mander BA, Zhu AH, Lindquist JR, Villeneuve S, Rao V, Lu B, Saletin JM, Ancoli-Israel S, Jagust W, Walker MP. White Matter Structure in Older Adults Moderates the Benefit of Sleep Spindles on Motor Memory Consolidation. J Neurosci. 2017 Nov 29; 37(48):11675-11687. PMID: 29084867.
      View in: PubMed
    20. Baker SL, Maass A, Jagust W. Considerations and code for partial volume correcting [18F]-AV-1451 tau PET data. Data Brief. 2017 Dec; 15:648-657. PMID: 29124088.
      View in: PubMed
    21. Vogel JW, Varga Doležalová M, La Joie R, Marks SM, Schwimmer HD, Landau SM, Jagust W. Subjective cognitive decline and β-amyloid burden predict cognitive change in healthy elderly. Neurology. 2017 Oct 06. PMID: 28986416.
      View in: PubMed
    22. Schonhaut DR, McMillan CT, Spina S, Dickerson BC, Siderowf A, Devous MD, Tsai R, Winer J, Russell DS, Litvan I, Roberson ED, Seeley WW, Grinberg LT, Kramer JH, Miller BL, Pressman P, Nasrallah I, Baker SL, Gomperts SN, Johnson KA, Grossman M, Jagust W, Boxer AL, Rabinovici GD. 18 F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study. Ann Neurol. 2017 Oct; 82(4):622-634. PMID: 28980714.
      View in: PubMed
    23. Iaccarino L, Tammewar G, Ayakta N, Baker SL, Bejanin A, Boxer AL, Gorno-Tempini ML, Janabi M, Kramer JH, Lazaris A, Lockhart SN, Miller BL, Miller ZA, O'Neil JP, Ossenkoppele R, Rosen HJ, Schonhaut DR, Jagust W, Rabinovici GD. Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease. Neuroimage Clin. 2018; 17:452-464. PMID: 29159058.
      View in: PubMed
    24. Berry AS, Shah VD, Furman DJ, White Iii RL, Baker SL, O'Neil JP, Janabi M, D'Esposito M, Jagust W. Dopamine Synthesis Capacity is Associated with D2/3 Receptor Binding but Not Dopamine Release. Neuropsychopharmacology. 2018 May; 43(6):1201-1211. PMID: 28816243.
      View in: PubMed
    25. Schreiber S, Schreiber F, Lockhart SN, Horng A, Bejanin A, Landau SM, Jagust W. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology. JAMA Neurol. 2017 Jun 01; 74(6):650-659. PMID: 28319241.
      View in: PubMed
    26. Insel PS, Ossenkoppele R, Gessert D, Jagust W, Landau S, Hansson O, Weiner MW, Mattsson N. Time to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's Disease. Front Neurosci. 2017; 11:281. PMID: 28567001.
      View in: PubMed
    27. Tosun D, Landau S, Aisen PS, Petersen RC, Mintun M, Jagust W, Weiner MW. Association between tau deposition and antecedent amyloid-ß accumulation rates in normal and early symptomatic individuals. Brain. 2017 May 01; 140(5):1499-1512. PMID: 28334939.
      View in: PubMed
    28. Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Morris JC, Petersen RC, Saykin AJ, Shaw LM, Toga AW, Trojanowski JQ. Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials. Alzheimers Dement. 2017 Apr; 13(4):e1-e85. PMID: 28342697.
      View in: PubMed
    29. Lockhart SN, Schöll M, Baker SL, Ayakta N, Swinnerton KN, Bell RK, Mellinger TJ, Shah VD, O'Neil JP, Janabi M, Jagust W. Amyloid and tau PET demonstrate region-specific associations in normal older people. Neuroimage. 2017 Apr 15; 150:191-199. PMID: 28232190.
      View in: PubMed
    30. Marks SM, Lockhart SN, Baker SL, Jagust W. Tau and ß-Amyloid Are Associated with Medial Temporal Lobe Structure, Function, and Memory Encoding in Normal Aging. J Neurosci. 2017 Mar 22; 37(12):3192-3201. PMID: 28213439.
      View in: PubMed
    31. Lockhart SN, Ayakta N, Winer JR, La Joie R, Rabinovici GD, Jagust W. Elevated 18F-AV-1451 PET tracer uptake detected in incidental imaging findings. Neurology. 2017 Mar 14; 88(11):1095-1097. PMID: 28188303.
      View in: PubMed
    32. Leal SL, Landau SM, Bell RK, Jagust W. Hippocampal activation is associated with longitudinal amyloid accumulation and cognitive decline. Elife. 2017 Feb 08; 6. PMID: 28177283.
      View in: PubMed
    33. Spina S, Schonhaut DR, Boeve BF, Seeley WW, Ossenkoppele R, O'Neil JP, Lazaris A, Rosen HJ, Boxer AL, Perry DC, Miller BL, Dickson DW, Parisi JE, Jagust W, Murray ME, Rabinovici GD. Frontotemporal dementia with the V337M MAPT mutation: Tau-PET and pathology correlations. Neurology. 2017 Feb 21; 88(8):758-766. PMID: 28130473.
      View in: PubMed
    34. Liu CY, Ohki Y, Tomita T, Osawa S, Reed BR, Jagust W, Van Berlo V, Jin LW, Chui HC, Coppola G, Ringman JM. Two Novel Mutations in the First Transmembrane Domain of Presenilin1 Cause Young-Onset Alzheimer's Disease. J Alzheimers Dis. 2017; 58(4):1035-1041. PMID: 28550247.
      View in: PubMed
    35. Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Morris JC, Petersen RC, Salazar J, Saykin AJ, Shaw LM, Toga AW, Trojanowski JQ. The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement. Alzheimers Dement. 2017 May; 13(5):561-571. PMID: 27931796.
      View in: PubMed
    36. Berry AS, Shah VD, Baker SL, Vogel JW, O'Neil JP, Janabi M, Schwimmer HD, Marks SM, Jagust W. Aging Affects Dopaminergic Neural Mechanisms of Cognitive Flexibility. J Neurosci. 2016 Dec 14; 36(50):12559-12569. PMID: 27807030.
      View in: PubMed
    37. Yassine HN, Feng Q, Azizkhanian I, Rawat V, Castor K, Fonteh AN, Harrington MG, Zheng L, Reed BR, DeCarli C, Jagust W, Chui HC. Association of Serum Docosahexaenoic Acid With Cerebral Amyloidosis. JAMA Neurol. 2016 Oct 01; 73(10):1208-1216. PMID: 27532692.
      View in: PubMed
    38. Jagust W. Tau and ß-Amyloid-The Malignant Duo. JAMA Neurol. 2016 Sep 01; 73(9):1049-50. PMID: 27454015.
      View in: PubMed
    39. Baker SL, Lockhart SN, Price JC, He M, Huesman RH, Schonhaut D, Faria J, Rabinovici G, Jagust W. Reference Tissue-Based Kinetic Evaluation of 18F-AV-1451 for Tau Imaging. J Nucl Med. 2017 Feb; 58(2):332-338. PMID: 27587706.
      View in: PubMed
    40. Babiloni C, Del Percio C, Caroli A, Salvatore E, Nicolai E, Marzano N, Lizio R, Cavedo E, Landau S, Chen K, Jagust W, Reiman E, Tedeschi G, Montella P, De Stefano M, Gesualdo L, Frisoni GB, Soricelli A. Cortical sources of resting state EEG rhythms are related to brain hypometabolism in subjects with Alzheimer's disease: an EEG-PET study. Neurobiol Aging. 2016 12; 48:122-134. PMID: 27668356.
      View in: PubMed
    41. Tosun D, Schuff N, Rabinovici GD, Ayakta N, Miller BL, Jagust W, Kramer J, Weiner MM, Rosen HJ. Diagnostic utility of ASL-MRI and FDG-PET in the behavioral variant of FTD and AD. Ann Clin Transl Neurol. 2016 Oct; 3(10):740-751. PMID: 27752510.
      View in: PubMed
    42. Jagust W. Early life sets the stage for aging. Proc Natl Acad Sci U S A. 2016 08 16; 113(33):9148-50. PMID: 27436907; PMCID: PMC4995968 [Available on 02/16/17].
    43. Ballarini T, Iaccarino L, Magnani G, Ayakta N, Miller BL, Jagust W, Gorno-Tempini ML, Rabinovici GD, Perani D. Neuropsychiatric subsyndromes and brain metabolic network dysfunctions in early onset Alzheimer's disease. Hum Brain Mapp. 2016 12; 37(12):4234-4247. PMID: 27412866.
      View in: PubMed
    44. Jack CR, Bennett DA, Blennow K, Carrillo MC, Feldman HH, Frisoni GB, Hampel H, Jagust W, Johnson KA, Knopman DS, Petersen RC, Scheltens P, Sperling RA, Dubois B. A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology. 2016 Aug 02; 87(5):539-47. PMID: 27371494; PMCID: PMC4970664.
    45. Lockhart SN, Baker SL, Okamura N, Furukawa K, Ishiki A, Furumoto S, Tashiro M, Yanai K, Arai H, Kudo Y, Harada R, Tomita N, Hiraoka K, Watanuki S, Jagust W. Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer's Disease Patients Measured Using [18F] THK-5351. PLoS One. 2016; 11(6):e0158460. PMID: 27355840; PMCID: PMC4927104.
    46. Chételat G, Ossenkoppele R, Villemagne VL, Perrotin A, Landeau B, Mézenge F, Jagust W, Dore V, Miller BL, Egret S, Seeley WW, van der Flier WM, La Joie R, Ames D, van Berckel BN, Scheltens P, Barkhof F, Rowe CC, Masters CL, de La Sayette V, Bouwman F, Rabinovici GD. Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease. Brain. 2016 09; 139(Pt 9):2528-39. PMID: 27357349.
      View in: PubMed
    47. Mander BA, Winer JR, Jagust W, Walker MP. Sleep: A Novel Mechanistic Pathway, Biomarker, and Treatment Target in the Pathology of Alzheimer's Disease? Trends Neurosci. 2016 08; 39(8):552-566. PMID: 27325209.
      View in: PubMed
    48. Risacher SL, McDonald BC, Tallman EF, West JD, Farlow MR, Unverzagt FW, Gao S, Boustani M, Crane PK, Petersen RC, Jack CR, Jagust W, Aisen PS, Weiner MW, Saykin AJ. Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults. JAMA Neurol. 2016 Jun 01; 73(6):721-32. PMID: 27088965.
      View in: PubMed
    49. Oh H, Madison C, Baker S, Rabinovici G, Jagust W. Dynamic relationships between age, amyloid-ß deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease. Brain. 2016 08; 139(Pt 8):2275-89. PMID: 27190008; PMCID: PMC4958895 [Available on 08/01/17].
    50. Insel PS, Mattsson N, Mackin RS, Schöll M, Nosheny RL, Tosun D, Donohue MC, Aisen PS, Jagust W, Weiner MW. Accelerating rates of cognitive decline and imaging markers associated with ß-amyloid pathology. Neurology. 2016 05 17; 86(20):1887-96. PMID: 27164667.
      View in: PubMed
    51. Landau SM, Horng A, Fero A, Jagust W. Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI. Neurology. 2016 Apr 12; 86(15):1377-85. PMID: 26968515; PMCID: PMC4831042 [Available on 04/12/17].
    52. Ossenkoppele R, Schonhaut DR, Schöll M, Lockhart SN, Ayakta N, Baker SL, O'Neil JP, Janabi M, Lazaris A, Cantwell A, Vogel J, Santos M, Miller ZA, Bettcher BM, Vossel KA, Kramer JH, Gorno-Tempini ML, Miller BL, Jagust W, Rabinovici GD. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. Brain. 2016 05; 139(Pt 5):1551-67. PMID: 26962052; PMCID: PMC5006248 [Available on 05/01/17].
    53. Schöll M, Lockhart SN, Schonhaut DR, O'Neil JP, Janabi M, Ossenkoppele R, Baker SL, Vogel JW, Faria J, Schwimmer HD, Rabinovici GD, Jagust W. PET Imaging of Tau Deposition in the Aging Human Brain. Neuron. 2016 Mar 02; 89(5):971-982. PMID: 26938442; PMCID: PMC4779187 [Available on 03/02/17].
    54. Fletcher E, Villeneuve S, Maillard P, Harvey D, Reed B, Jagust W, DeCarli C. ß-amyloid, hippocampal atrophy and their relation to longitudinal brain change in cognitively normal individuals. Neurobiol Aging. 2016 Apr; 40:173-180. PMID: 26973117.
      View in: PubMed
    55. Schreiber S, Vogel J, Schwimmer HD, Marks SM, Schreiber F, Jagust W. Impact of lifestyle dimensions on brain pathology and cognition. Neurobiol Aging. 2016 Apr; 40:164-172. PMID: 26973116.
      View in: PubMed
    56. Jack CR, Knopman DS, Chételat G, Dickson D, Fagan AM, Frisoni GB, Jagust W, Mormino EC, Petersen RC, Sperling RA, van der Flier WM, Villemagne VL, Visser PJ, Vos SJ. Suspected non-Alzheimer disease pathophysiology--concept and controversy. Nat Rev Neurol. 2016 Feb; 12(2):117-24. PMID: 26782335; PMCID: PMC4784257.
    57. Jung NY, Han CE, Kim HJ, Yoo SW, Kim HJ, Kim EJ, Na DL, Lockhart SN, Jagust W, Seong JK, Seo SW. Tract-Specific Correlates of Neuropsychological Deficits in Patients with Subcortical Vascular Cognitive Impairment. J Alzheimers Dis. 2016; 50(4):1125-35. PMID: 26836179.
      View in: PubMed
    58. Smith CT, Wallace DL, Dang LC, Aarts E, Jagust W, D'Esposito M, Boettiger CA. Modulation of impulsivity and reward sensitivity in intertemporal choice by striatal and midbrain dopamine synthesis in healthy adults. J Neurophysiol. 2016 Mar; 115(3):1146-56. PMID: 26683066; PMCID: PMC4808128 [Available on 03/01/17].
    59. Jagust W. Is amyloid-ß harmful to the brain? Insights from human imaging studies. Brain. 2016 Jan; 139(Pt 1):23-30. PMID: 26614753.
      View in: PubMed
    60. Tosun D, Schuff N, Jagust W, Weiner MW. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-ß-Positive Subjects in the Alzheimer's Disease Continuum. Neurodegener Dis. 2016; 16(1-2):87-94. PMID: 26560336.
      View in: PubMed
    61. Lazaris A, Hwang KS, Goukasian N, Ramirez LM, Eastman J, Blanken AE, Teng E, Gylys K, Cole G, Saykin AJ, Shaw LM, Trojanowski JQ, Jagust W, Weiner MW, Apostolova LG. Alzheimer risk genes modulate the relationship between plasma apoE and cortical PiB binding. Neurol Genet. 2015 Oct; 1(3):e22. PMID: 27066559; PMCID: PMC4809461.
    62. Schreiber S, Landau SM, Fero A, Schreiber F, Jagust W. Comparison of Visual and Quantitative Florbetapir F 18 Positron Emission Tomography Analysis in Predicting Mild Cognitive Impairment Outcomes. JAMA Neurol. 2015 Oct; 72(10):1183-90. PMID: 26280102.
      View in: PubMed
    63. Altmann A, Ng B, Landau SM, Jagust W, Greicius MD. Regional brain hypometabolism is unrelated to regional amyloid plaque burden. Brain. 2015 Dec; 138(Pt 12):3734-46. PMID: 26419799; PMCID: PMC4806718 [Available on 12/01/16].
    64. Ossenkoppele R, Cohn-Sheehy BI, La Joie R, Vogel JW, Möller C, Lehmann M, van Berckel BN, Seeley WW, Pijnenburg YA, Gorno-Tempini ML, Kramer JH, Barkhof F, Rosen HJ, van der Flier WM, Jagust W, Miller BL, Scheltens P, Rabinovici GD. Atrophy patterns in early clinical stages across distinct phenotypes of Alzheimer's disease. Hum Brain Mapp. 2015 Nov; 36(11):4421-37. PMID: 26260856; PMCID: PMC4692964.
    65. Ramanan VK, Risacher SL, Nho K, Kim S, Shen L, McDonald BC, Yoder KK, Hutchins GD, West JD, Tallman EF, Gao S, Foroud TM, Farlow MR, De Jager PL, Bennett DA, Aisen PS, Petersen RC, Jack CR, Toga AW, Green RC, Jagust W, Weiner MW, Saykin AJ. GWAS of longitudinal amyloid accumulation on 18F-florbetapir PET in Alzheimer's disease implicates microglial activation gene IL1RAP. Brain. 2015 Oct; 138(Pt 10):3076-88. PMID: 26268530; PMCID: PMC4671479 [Available on 10/01/16].
    66. Lehmann M, Madison C, Ghosh PM, Miller ZA, Greicius MD, Kramer JH, Coppola G, Miller BL, Jagust W, Gorno-Tempini ML, Seeley WW, Rabinovici GD. Loss of functional connectivity is greater outside the default mode network in nonfamilial early-onset Alzheimer's disease variants. Neurobiol Aging. 2015 Oct; 36(10):2678-86. PMID: 26242705; PMCID: PMC4698410.
    67. Ossenkoppele R, Pijnenburg YA, Perry DC, Cohn-Sheehy BI, Scheltens NM, Vogel JW, Kramer JH, van der Vlies AE, La Joie R, Rosen HJ, van der Flier WM, Grinberg LT, Rozemuller AJ, Huang EJ, van Berckel BN, Miller BL, Barkhof F, Jagust W, Scheltens P, Seeley WW, Rabinovici GD. The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features. Brain. 2015 Sep; 138(Pt 9):2732-49. PMID: 26141491; PMCID: PMC4623840.
    68. Jagust W, Landau SM, Koeppe RA, Reiman EM, Chen K, Mathis CA, Price JC, Foster NL, Wang AY. The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015. Alzheimers Dement. 2015 Jul; 11(7):757-71. PMID: 26194311; PMCID: PMC4510459.
    69. Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J, Donohue MC, Green RC, Harvey D, Jack CR, Jagust W, Morris JC, Petersen RC, Saykin AJ, Shaw L, Thompson PM, Toga AW, Trojanowski JQ. Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014. Alzheimers Dement. 2015 Jul; 11(7):865-84. PMID: 26194320.
      View in: PubMed
    70. Naasan G, Rabinovici GD, Ghosh P, Elofson JD, Miller BL, Coppola G, Karydas A, Fong J, Perry D, Lee SE, Yokoyama JS, Seeley WW, Kramer JH, Weiner MW, Schuff N, Jagust W, Grinberg LT, Pribadi M, Yang Z, Sears R, Klein E, Wojta K, Rosen HJ. Amyloid in dementia associated with familial FTLD: not an innocent bystander. Neurocase. 2016; 22(1):76-83. PMID: 26040468; PMCID: PMC4662906 [Available on 02/01/17].
    71. Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J, Green RC, Harvey D, Jack CR, Jagust W, Luthman J, Morris JC, Petersen RC, Saykin AJ, Shaw L, Shen L, Schwarz A, Toga AW, Trojanowski JQ. 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception. Alzheimers Dement. 2015 Jun; 11(6):e1-120. PMID: 26073027.
      View in: PubMed
    72. Mander BA, Marks SM, Vogel JW, Rao V, Lu B, Saletin JM, Ancoli-Israel S, Jagust W, Walker MP. ß-amyloid disrupts human NREM slow waves and related hippocampus-dependent memory consolidation. Nat Neurosci. 2015 Jul; 18(7):1051-7. PMID: 26030850.
      View in: PubMed
    73. Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FR, Visser PJ. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. JAMA. 2015 May 19; 313(19):1924-38. PMID: 25988462; PMCID: PMC4486209.
    74. Ossenkoppele R, Jansen WJ, Rabinovici GD, Knol DL, van der Flier WM, van Berckel BN, Scheltens P, Visser PJ. Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. JAMA. 2015 May 19; 313(19):1939-49. PMID: 25988463; PMCID: PMC4517678.
    75. Wallace DL, Aarts E, d'Oleire Uquillas F, Dang LC, Greer SM, Jagust W, D'Esposito M. Genotype status of the dopamine-related catechol-O-methyltransferase (COMT) gene corresponds with desirability of "unhealthy" foods. Appetite. 2015 Sep; 92:74-80. PMID: 25963102; PMCID: PMC4629853.
    76. Risacher SL, Kim S, Nho K, Foroud T, Shen L, Petersen RC, Jack CR, Beckett LA, Aisen PS, Koeppe RA, Jagust W, Shaw LM, Trojanowski JQ, Weiner MW, Saykin AJ. APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern. Alzheimers Dement. 2015 Dec; 11(12):1417-1429. PMID: 25960448.
      View in: PubMed
    77. Villeneuve S, Rabinovici GD, Cohn-Sheehy BI, Madison C, Ayakta N, Ghosh PM, La Joie R, Arthur-Bentil SK, Vogel JW, Marks SM, Lehmann M, Rosen HJ, Reed B, Olichney J, Boxer AL, Miller BL, Borys E, Jin LW, Huang EJ, Grinberg LT, DeCarli C, Seeley WW, Jagust W. Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation. Brain. 2015 Jul; 138(Pt 7):2020-33. PMID: 25953778; PMCID: PMC4806716.
    78. Toledo JB, Bjerke M, Da X, Landau SM, Foster NL, Jagust W, Jack C, Weiner M, Davatzikos C, Shaw LM, Trojanowski JQ. Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 ß-Amyloid Measures Across the Spectrum of Alzheimer Disease. JAMA Neurol. 2015 May; 72(5):571-81. PMID: 25822737.
      View in: PubMed
    79. Mattsson N, Insel PS, Donohue M, Jagust W, Sperling R, Aisen P, Weiner MW. Predicting Reduction of Cerebrospinal Fluid ß-Amyloid 42 in Cognitively Healthy Controls. JAMA Neurol. 2015 May; 72(5):554-60. PMID: 25775167.
      View in: PubMed
    80. Boutchko R, Mitra D, Baker SL, Jagust W, Gullberg GT. Clustering-initiated factor analysis application for tissue classification in dynamic brain positron emission tomography. J Cereb Blood Flow Metab. 2015 Jul; 35(7):1104-11. PMID: 25899294; PMCID: PMC4640278.
    81. Caroli A, Prestia A, Wade S, Chen K, Ayutyanont N, Landau SM, Madison CM, Haense C, Herholz K, Reiman EM, Jagust W, Frisoni GB. Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI. Alzheimer Dis Assoc Disord. 2015 Apr-Jun; 29(2):101-9. PMID: 25437302; PMCID: PMC4437812.
    82. Chen K, Roontiva A, Thiyyagura P, Lee W, Liu X, Ayutyanont N, Protas H, Luo JL, Bauer R, Reschke C, Bandy D, Koeppe RA, Fleisher AS, Caselli RJ, Landau S, Jagust W, Weiner MW, Reiman EM. Improved power for characterizing longitudinal amyloid-ß PET changes and evaluating amyloid-modifying treatments with a cerebral white matter reference region. J Nucl Med. 2015 Apr; 56(4):560-6. PMID: 25745091.
      View in: PubMed
    83. Landau SM, Fero A, Baker SL, Koeppe R, Mintun M, Chen K, Reiman EM, Jagust W. Measurement of longitudinal ß-amyloid change with 18F-florbetapir PET and standardized uptake value ratios. J Nucl Med. 2015 Apr; 56(4):567-74. PMID: 25745095.
      View in: PubMed
    84. Villeneuve S, Jagust W. Imaging Vascular Disease and Amyloid in the Aging Brain: Implications for Treatment. J Prev Alzheimers Dis. 2015 Mar; 2(1):64-70. PMID: 25844350.
      View in: PubMed
    85. Mattsson N, Insel PS, Aisen PS, Jagust W, Mackin S, Weiner M. Brain structure and function as mediators of the effects of amyloid on memory. Neurology. 2015 Mar 17; 84(11):1136-44. PMID: 25681451.
      View in: PubMed
    86. Apostolova LG, Hwang KS, Avila D, Elashoff D, Kohannim O, Teng E, Sokolow S, Jack CR, Jagust W, Shaw L, Trojanowski JQ, Weiner MW, Thompson PM. Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures. Neurology. 2015 Feb 17; 84(7):729-37. PMID: 25609767; PMCID: PMC4336101.
    87. Mattsson N, Insel PS, Donohue M, Landau S, Jagust W, Shaw LM, Trojanowski JQ, Zetterberg H, Blennow K, Weiner MW. Independent information from cerebrospinal fluid amyloid-ß and florbetapir imaging in Alzheimer's disease. Brain. 2015 Mar; 138(Pt 3):772-83. PMID: 25541191; PMCID: PMC4339769.
    88. Ossenkoppele R, Schonhaut DR, Baker SL, O'Neil JP, Janabi M, Ghosh PM, Santos M, Miller ZA, Bettcher BM, Gorno-Tempini ML, Miller BL, Jagust W, Rabinovici GD. Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophy. Ann Neurol. 2015 Feb; 77(2):338-42. PMID: 25448043; PMCID: PMC4382124.
    89. Schmidt ME, Chiao P, Klein G, Matthews D, Thurfjell L, Cole PE, Margolin R, Landau S, Foster NL, Mason NS, De Santi S, Suhy J, Koeppe RA, Jagust W. The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal data. Alzheimers Dement. 2015 Sep; 11(9):1050-68. PMID: 25457431.
      View in: PubMed
    90. Schicktanz S, Schweda M, Ballenger JF, Fox PJ, Halpern J, Kramer JH, Micco G, Post SG, Thompson C, Knight RT, Jagust W. Before it is too late: professional responsibilities in late-onset Alzheimer's research and pre-symptomatic prediction. Front Hum Neurosci. 2014; 8:921. PMID: 25477802; PMCID: PMC4238325.
    91. Elman JA, Madison CM, Baker SL, Vogel JW, Marks SM, Crowley S, O'Neil JP, Jagust W. Effects of Beta-Amyloid on Resting State Functional Connectivity Within and Between Networks Reflect Known Patterns of Regional Vulnerability. Cereb Cortex. 2016 Feb; 26(2):695-707. PMID: 25405944.
      View in: PubMed
    92. Dowling NM, Johnson SC, Gleason CE, Jagust W. The mediational effects of FDG hypometabolism on the association between cerebrospinal fluid biomarkers and neurocognitive function. Neuroimage. 2015 Jan 15; 105:357-68. PMID: 25450107.
      View in: PubMed
    93. Klunk WE, Koeppe RA, Price JC, Benzinger TL, Devous MD, Jagust W, Johnson KA, Mathis CA, Minhas D, Pontecorvo MJ, Rowe CC, Skovronsky DM, Mintun MA. The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET. Alzheimers Dement. 2015 Jan; 11(1):1-15.e1-4. PMID: 25443857.
      View in: PubMed
    94. Elman JA, Oh H, Madison CM, Baker SL, Vogel JW, Marks SM, Crowley S, O'Neil JP, Jagust W. Neural compensation in older people with brain amyloid-ß deposition. Nat Neurosci. 2014 Oct; 17(10):1316-8. PMID: 25217827; PMCID: PMC4177011.
    95. Mattsson N, Insel PS, Landau S, Jagust W, Donohue M, Shaw LM, Trojanowski JQ, Zetterberg H, Blennow K, Weiner M. Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease. Ann Clin Transl Neurol. 2014 Aug; 1(8):534-43. PMID: 25356425; PMCID: PMC4184556.
    96. Wirth M, Villeneuve S, La Joie R, Marks SM, Jagust W. Gene-environment interactions: lifetime cognitive activity, APOE genotype, and ß-amyloid burden. J Neurosci. 2014 Jun 18; 34(25):8612-7. PMID: 24948815; PMCID: PMC4061397.
    97. Villeneuve S, Reed BR, Madison CM, Wirth M, Marchant NL, Kriger S, Mack WJ, Sanossian N, DeCarli C, Chui HC, Weiner MW, Jagust W. Vascular risk and Aß interact to reduce cortical thickness in AD vulnerable brain regions. Neurology. 2014 Jul 01; 83(1):40-7. PMID: 24907234; PMCID: PMC4114172.
    98. Weiner MW, Veitch DP, Hayes J, Neylan T, Grafman J, Aisen PS, Petersen RC, Jack C, Jagust W, Trojanowski JQ, Shaw LM, Saykin AJ, Green RC, Harvey D, Toga AW, Friedl KE, Pacifico A, Sheline Y, Yaffe K, Mohlenoff B. Effects of traumatic brain injury and posttraumatic stress disorder on Alzheimer's disease in veterans, using the Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement. 2014 Jun; 10(3 Suppl):S226-35. PMID: 24924673; PMCID: PMC4392759.
    99. Wallace DL, Aarts E, Dang LC, Greer SM, Jagust W, D'Esposito M. Dorsal striatal dopamine, food preference and health perception in humans. PLoS One. 2014; 9(5):e96319. PMID: 24806534; PMCID: PMC4012945.
    100. Jagust W. Time for tau. Brain. 2014 Jun; 137(Pt 6):1570-1. PMID: 24736306.
      View in: PubMed
    101. Laforce R, Tosun D, Ghosh P, Lehmann M, Madison CM, Weiner MW, Miller BL, Jagust W, Rabinovici GD. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology. Neuroimage Clin. 2014; 4:508-16. PMID: 24818077; PMCID: PMC3984448.
    102. Mattsson N, Tosun D, Insel PS, Simonson A, Jack CR, Beckett LA, Donohue M, Jagust W, Schuff N, Weiner MW. Association of brain amyloid-ß with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment. Brain. 2014 May; 137(Pt 5):1550-61. PMID: 24625697.
      View in: PubMed
    103. Toledo JB, Weiner MW, Wolk DA, Da X, Chen K, Arnold SE, Jagust W, Jack C, Reiman EM, Davatzikos C, Shaw LM, Trojanowski JQ. Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition. Acta Neuropathol Commun. 2014 Mar 06; 2:26. PMID: 24602322; PMCID: PMC4008258.
    104. Wirth M, Haase CM, Villeneuve S, Vogel J, Jagust W. Neuroprotective pathways: lifestyle activity, brain pathology, and cognition in cognitively normal older adults. Neurobiol Aging. 2014 Aug; 35(8):1873-82. PMID: 24656834; PMCID: PMC4019766.
    105. Aarts E, Wallace DL, Dang LC, Jagust W, Cools R, D'Esposito M. Dopamine and the cognitive downside of a promised bonus. Psychol Sci. 2014 Apr; 25(4):1003-9. PMID: 24525265; PMCID: PMC4163051.
    106. Reed B, Villeneuve S, Mack W, DeCarli C, Chui HC, Jagust W. Associations between serum cholesterol levels and cerebral amyloidosis. JAMA Neurol. 2014 Feb; 71(2):195-200. PMID: 24378418; PMCID: PMC4083819.
    107. Lee JY, Park S, Mackin S, Ewers M, Chui H, Jagust W, Insel PS, Weiner MW. Differences in prefrontal, limbic, and white matter lesion volumes according to cognitive status in elderly patients with first-onset subsyndromal depression. PLoS One. 2014; 9(1):e87747. PMID: 24498184; PMCID: PMC3909227.
    108. Villeneuve S, Reed BR, Wirth M, Haase CM, Madison CM, Ayakta N, Mack W, Mungas D, Chui HC, DeCarli C, Weiner MW, Jagust W. Cortical thickness mediates the effect of ß-amyloid on episodic memory. Neurology. 2014 Mar 04; 82(9):761-7. PMID: 24489134; PMCID: PMC3945649.
    109. Sánchez-Juan P, Ghosh PM, Hagen J, Gesierich B, Henry M, Grinberg LT, O'Neil JP, Janabi M, Huang EJ, Trojanowski JQ, Vinters HV, Gorno-Tempini M, Seeley WW, Boxer AL, Rosen HJ, Kramer JH, Miller BL, Jagust W, Rabinovici GD. Practical utility of amyloid and FDG-PET in an academic dementia center. Neurology. 2014 Jan 21; 82(3):230-8. PMID: 24353340; PMCID: PMC3902757.
    110. Landau SM, Lu M, Joshi AD, Pontecorvo M, Mintun MA, Trojanowski JQ, Shaw LM, Jagust W. Comparing positron emission tomography imaging and cerebrospinal fluid measurements of ß-amyloid. Ann Neurol. 2013 Dec; 74(6):826-36. PMID: 23536396; PMCID: PMC3748164.
    111. Wirth M, Villeneuve S, Haase CM, Madison CM, Oh H, Landau SM, Rabinovici GD, Jagust W. Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people. JAMA Neurol. 2013 Dec; 70(12):1512-9. PMID: 24166579; PMCID: PMC4962545.
    112. Oh H, Jagust W. Frontotemporal network connectivity during memory encoding is increased with aging and disrupted by beta-amyloid. J Neurosci. 2013 Nov 20; 33(47):18425-37. PMID: 24259567; PMCID: PMC3834050.
    113. Lo RY, Jagust W. Effect of cognitive reserve markers on Alzheimer pathologic progression. Alzheimer Dis Assoc Disord. 2013 Oct-Dec; 27(4):343-50. PMID: 23552443; PMCID: PMC3745532.
    114. Jagust W. Biomarkers and brain connectivity. JAMA Neurol. 2013 Oct; 70(10):1233-4. PMID: 23959142.
      View in: PubMed
    115. Lehmann M, Ghosh PM, Madison C, Karydas A, Coppola G, O'Neil JP, Huang Y, Miller BL, Jagust W, Rabinovici GD. Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients. J Neurol Neurosurg Psychiatry. 2014 Mar; 85(3):266-73. PMID: 23965289; PMCID: PMC3946299.
    116. Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Liu E, Morris JC, Petersen RC, Saykin AJ, Schmidt ME, Shaw L, Shen L, Siuciak JA, Soares H, Toga AW, Trojanowski JQ. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement. 2013 Sep; 9(5):e111-94. PMID: 23932184; PMCID: PMC4108198.
    117. Haight TJ, Landau SM, Carmichael O, Schwarz C, DeCarli C, Jagust W. Dissociable effects of Alzheimer disease and white matter hyperintensities on brain metabolism. JAMA Neurol. 2013 Aug; 70(8):1039-45. PMID: 23779022; PMCID: PMC3779687.
    118. Frisoni GB, Bocchetta M, Chételat G, Rabinovici GD, de Leon MJ, Kaye J, Reiman EM, Scheltens P, Barkhof F, Black SE, Brooks DJ, Carrillo MC, Fox NC, Herholz K, Nordberg A, Jack CR, Jagust W, Johnson KA, Rowe CC, Sperling RA, Thies W, Wahlund LO, Weiner MW, Pasqualetti P, Decarli C. Imaging markers for Alzheimer disease: which vs how. Neurology. 2013 Jul 30; 81(5):487-500. PMID: 23897875; PMCID: PMC3776529.
    119. Mander BA, Rao V, Lu B, Saletin JM, Ancoli-Israel S, Jagust W, Walker MP. Impaired prefrontal sleep spindle regulation of hippocampal-dependent learning in older adults. Cereb Cortex. 2014 Dec; 24(12):3301-9. PMID: 23901074; PMCID: PMC4224242.
    120. Lehmann M, Madison CM, Ghosh PM, Seeley WW, Mormino E, Greicius MD, Gorno-Tempini ML, Kramer JH, Miller BL, Jagust W, Rabinovici GD. Intrinsic connectivity networks in healthy subjects explain clinical variability in Alzheimer's disease. Proc Natl Acad Sci U S A. 2013 Jul 09; 110(28):11606-11. PMID: 23798398; PMCID: PMC3710820.
    121. Mitchell JM, O'Neil JP, Jagust W, Fields HL. Catechol-O-methyltransferase genotype modulates opioid release in decision circuitry. Clin Transl Sci. 2013 Oct; 6(5):400-3. PMID: 24127930.
      View in: PubMed
    122. Chao LL, Decarli C, Kriger S, Truran D, Zhang Y, Laxamana J, Villeneuve S, Jagust W, Sanossian N, Mack WJ, Chui HC, Weiner MW. Associations between white matter hyperintensities and ß amyloid on integrity of projection, association, and limbic fiber tracts measured with diffusion tensor MRI. PLoS One. 2013; 8(6):e65175. PMID: 23762308.
      View in: PubMed
    123. Risacher SL, Kim S, Shen L, Nho K, Foroud T, Green RC, Petersen RC, Jack CR, Aisen PS, Koeppe RA, Jagust W, Shaw LM, Trojanowski JQ, Weiner MW, Saykin AJ. The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI). Front Aging Neurosci. 2013; 5:11. PMID: 23554593; PMCID: PMC3612590.
    124. Marchant NL, Reed BR, Sanossian N, Madison CM, Kriger S, Dhada R, Mack WJ, DeCarli C, Weiner MW, Mungas DM, Chui HC, Jagust W. The aging brain and cognition: contribution of vascular injury and aß to mild cognitive dysfunction. JAMA Neurol. 2013 Apr; 70(4):488-95. PMID: 23400560; PMCID: PMC3771392.
    125. Ossenkoppele R, Madison C, Oh H, Wirth M, van Berckel BN, Jagust W. Is verbal episodic memory in elderly with amyloid deposits preserved through altered neuronal function? Cereb Cortex. 2014 Aug; 24(8):2210-8. PMID: 23537530; PMCID: PMC4089385.
    126. Wirth M, Madison CM, Rabinovici GD, Oh H, Landau SM, Jagust W. Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not ß-amyloid in cognitively normal older individuals. J Neurosci. 2013 Mar 27; 33(13):5553-63. PMID: 23536070; PMCID: PMC3687777.
    127. Swaminathan S, Risacher SL, Yoder KK, West JD, Shen L, Kim S, Inlow M, Foroud T, Jagust W, Koeppe RA, Mathis CA, Shaw LM, Trojanowski JQ, Soares H, Aisen PS, Petersen RC, Weiner MW, Saykin AJ. Association of plasma and cortical amyloid beta is modulated by APOE e4 status. Alzheimers Dement. 2014 Jan; 10(1):e9-e18. PMID: 23541187.
      View in: PubMed
    128. Wirth M, Oh H, Mormino EC, Markley C, Landau SM, Jagust W. The effect of amyloid ß on cognitive decline is modulated by neural integrity in cognitively normal elderly. Alzheimers Dement. 2013 Nov; 9(6):687-698.e1. PMID: 23474040; PMCID: PMC3823816.
    129. Jagust W. Apolipoprotein E, neurodegeneration, and Alzheimer disease. JAMA Neurol. 2013 Mar 01; 70(3):299-300. PMID: 23599927.
      View in: PubMed
    130. Oh H, Madison C, Villeneuve S, Markley C, Jagust W. Association of gray matter atrophy with age, ß-amyloid, and cognition in aging. Cereb Cortex. 2014 Jun; 24(6):1609-18. PMID: 23389995; PMCID: PMC4014182.
    131. Jack CR, Knopman DS, Jagust W, Petersen RC, Weiner MW, Aisen PS, Shaw LM, Vemuri P, Wiste HJ, Weigand SD, Lesnick TG, Pankratz VS, Donohue MC, Trojanowski JQ. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013 Feb; 12(2):207-16. PMID: 23332364; PMCID: PMC3622225.
    132. Kantarci K, Gunter JL, Tosakulwong N, Weigand SD, Senjem MS, Petersen RC, Aisen PS, Jagust W, Weiner MW, Jack CR. Focal hemosiderin deposits and ß-amyloid load in the ADNI cohort. Alzheimers Dement. 2013 Oct; 9(5 Suppl):S116-23. PMID: 23375568; PMCID: PMC3770782.
    133. Prestia A, Caroli A, Herholz K, Reiman E, Chen K, Jagust W, Frisoni GB. Diagnostic accuracy of markers for prodromal Alzheimer's disease in independent clinical series. Alzheimers Dement. 2013 Nov; 9(6):677-86. PMID: 23375562.
      View in: PubMed
    134. Lehmann M, Ghosh PM, Madison C, Laforce R, Corbetta-Rastelli C, Weiner MW, Greicius MD, Seeley WW, Gorno-Tempini ML, Rosen HJ, Miller BL, Jagust W, Rabinovici GD. Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease. Brain. 2013 Mar; 136(Pt 3):844-58. PMID: 23358601; PMCID: PMC3580269.
    135. Mander BA, Rao V, Lu B, Saletin JM, Lindquist JR, Ancoli-Israel S, Jagust W, Walker MP. Prefrontal atrophy, disrupted NREM slow waves and impaired hippocampal-dependent memory in aging. Nat Neurosci. 2013 Mar; 16(3):357-64. PMID: 23354332; PMCID: PMC4286370.
    136. Jagust W. Vulnerable neural systems and the borderland of brain aging and neurodegeneration. Neuron. 2013 Jan 23; 77(2):219-34. PMID: 23352159; PMCID: PMC3558930.
    137. Alkalay A, Rabinovici GD, Zimmerman G, Agarwal N, Kaufer D, Miller BL, Jagust W, Soreq H. Plasma acetylcholinesterase activity correlates with intracerebral ß-amyloid load. Curr Alzheimer Res. 2013 Jan; 10(1):48-56. PMID: 23157337; PMCID: PMC3768143.
    138. Foster NL, Jagust W, Fox NC. A peek behind the curtain: amyloid imaging, referrals, and specialist memory evaluations. Alzheimer Dis Assoc Disord. 2013 Jan-Mar; 27(1):1-3. PMID: 23411640.
      View in: PubMed
    139. Wu X, Li J, Ayutyanont N, Protas H, Jagust W, Fleisher A, Reiman E, Yao L, Chen K. The receiver operational characteristic for binary classification with multiple indices and its application to the neuroimaging study of Alzheimer's disease. IEEE/ACM Trans Comput Biol Bioinform. 2013 Jan-Feb; 10(1):173-80. PMID: 23702553.
      View in: PubMed
    140. Jagust W, Landau SM. Apolipoprotein E, not fibrillar ß-amyloid, reduces cerebral glucose metabolism in normal aging. J Neurosci. 2012 Dec 12; 32(50):18227-33. PMID: 23238736; PMCID: PMC3537830.
    141. Stricker NH, Dodge HH, Dowling NM, Han SD, Erosheva EA, Jagust W. CSF biomarker associations with change in hippocampal volume and precuneus thickness: implications for the Alzheimer's pathological cascade. Brain Imaging Behav. 2012 Dec; 6(4):599-609. PMID: 22614327.
      View in: PubMed
    142. Landau SM, Breault C, Joshi AD, Pontecorvo M, Mathis CA, Jagust W, Mintun MA. Amyloid-ß imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods. J Nucl Med. 2013 Jan; 54(1):70-7. PMID: 23166389; PMCID: PMC3747730.
    143. Dang LC, O'Neil JP, Jagust W. Genetic effects on behavior are mediated by neurotransmitters and large-scale neural networks. Neuroimage. 2013 Feb 01; 66:203-14. PMID: 23142068; PMCID: PMC3587048.
    144. Jagust W. Tracking brain amyloid-ß in presymptomatic Alzheimer's disease. Lancet Neurol. 2012 Dec; 11(12):1018-20. PMID: 23137951.
      View in: PubMed
    145. Toledo JB, Toledo E, Weiner MW, Jack CR, Jagust W, Lee VM, Shaw LM, Trojanowski JQ. Cardiovascular risk factors, cortisol, and amyloid-ß deposition in Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement. 2012 Nov; 8(6):483-9. PMID: 23102118.
      View in: PubMed
    146. Haight TJ, Jagust W. Relative contributions of biomarkers in Alzheimer's disease. Ann Epidemiol. 2012 Dec; 22(12):868-75. PMID: 23102709.
      View in: PubMed
    147. Landau SM, Mintun MA, Joshi AD, Koeppe RA, Petersen RC, Aisen PS, Weiner MW, Jagust W. Amyloid deposition, hypometabolism, and longitudinal cognitive decline. Ann Neurol. 2012 Oct; 72(4):578-86. PMID: 23109153; PMCID: PMC3786871.
    148. Cardenas VA, Reed B, Chao LL, Chui H, Sanossian N, DeCarli CC, Mack W, Kramer J, Hodis HN, Yan M, Buonocore MH, Carmichael O, Jagust W, Weiner MW. Associations among vascular risk factors, carotid atherosclerosis, and cortical volume and thickness in older adults. Stroke. 2012 Nov; 43(11):2865-70. PMID: 22984010; PMCID: PMC3732460.
    149. Lo RY, Jagust W. Vascular burden and Alzheimer disease pathologic progression. Neurology. 2012 Sep 25; 79(13):1349-55. PMID: 22972646.
      View in: PubMed
    150. Oh H, Habeck C, Madison C, Jagust W. Covarying alterations in Aß deposition, glucose metabolism, and gray matter volume in cognitively normal elderly. Hum Brain Mapp. 2014 Jan; 35(1):297-308. PMID: 22965806; PMCID: PMC3600112.
    151. Dang LC, O'Neil JP, Jagust W. Dopamine supports coupling of attention-related networks. J Neurosci. 2012 Jul 11; 32(28):9582-7. PMID: 22787044; PMCID: PMC3410707.
    152. Landau S, Jagust W. Physical Activity and AD-Related Pathology-Reply. Arch Neurol. 2012 Jul 01; 69(7):940-1. PMID: 23753644.
      View in: PubMed
    153. Dang LC, Donde A, Madison C, O'Neil JP, Jagust W. Striatal dopamine influences the default mode network to affect shifting between object features. J Cogn Neurosci. 2012 Sep; 24(9):1960-70. PMID: 22640392; PMCID: PMC3510672.
    154. Landau SM, Marks SM, Mormino EC, Rabinovici GD, Oh H, O'Neil JP, Wilson RS, Jagust W. Association of lifetime cognitive engagement and low ß-amyloid deposition. Arch Neurol. 2012 May; 69(5):623-29. PMID: 22271235; PMCID: PMC3747737.
    155. Lo RY, Jagust W. Predicting missing biomarker data in a longitudinal study of Alzheimer disease. Neurology. 2012 May 01; 78(18):1376-82. PMID: 22491869; PMCID: PMC3345787.
    156. Oh H, Madison C, Haight TJ, Markley C, Jagust W. Effects of age and ß-amyloid on cognitive changes in normal elderly people. Neurobiol Aging. 2012 Dec; 33(12):2746-55. PMID: 22429886; PMCID: PMC3381075.
    157. Swaminathan S, Shen L, Risacher SL, Yoder KK, West JD, Kim S, Nho K, Foroud T, Inlow M, Potkin SG, Huentelman MJ, Craig DW, Jagust W, Koeppe RA, Mathis CA, Jack CR, Weiner MW, Saykin AJ. Amyloid pathway-based candidate gene analysis of [(11)C]PiB-PET in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort. Brain Imaging Behav. 2012 Mar; 6(1):1-15. PMID: 21901424; PMCID: PMC3256261.
    158. Caroli A, Prestia A, Chen K, Ayutyanont N, Landau SM, Madison CM, Haense C, Herholz K, Nobili F, Reiman EM, Jagust W, Frisoni GB. Summary metrics to assess Alzheimer disease-related hypometabolic pattern with 18F-FDG PET: head-to-head comparison. J Nucl Med. 2012 Apr; 53(4):592-600. PMID: 22343502; PMCID: PMC3640308.
    159. Bakken TE, Roddey JC, Djurovic S, Akshoomoff N, Amaral DG, Bloss CS, Casey BJ, Chang L, Ernst TM, Gruen JR, Jernigan TL, Kaufmann WE, Kenet T, Kennedy DN, Kuperman JM, Murray SS, Sowell ER, Rimol LM, Mattingsdal M, Melle I, Agartz I, Andreassen OA, Schork NJ, Dale AM. Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proc Natl Acad Sci U S A. 2012 Mar 06; 109(10):3985-90. PMID: 22343285.
      View in: PubMed
    160. Villemagne VL, Klunk WE, Mathis CA, Rowe CC, Brooks DJ, Hyman BT, Ikonomovic MD, Ishii K, Jack CR, Jagust W, Johnson KA, Koeppe RA, Lowe VJ, Masters CL, Montine TJ, Morris JC, Nordberg A, Petersen RC, Reiman EM, Selkoe DJ, Sperling RA, Van Laere K, Weiner MW, Drzezga A. Aß Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2012 Feb; 39(2):209-19. PMID: 22218879; PMCID: PMC3261395.
    161. Perrotin A, Mormino EC, Madison CM, Hayenga AO, Jagust W. Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron emission tomography study in normal elderly individuals. Arch Neurol. 2012 Feb; 69(2):223-9. PMID: 22332189; PMCID: PMC4004919.
    162. Mitchell JM, O'Neil JP, Janabi M, Marks SM, Jagust W, Fields HL. Alcohol consumption induces endogenous opioid release in the human orbitofrontal cortex and nucleus accumbens. Sci Transl Med. 2012 Jan 11; 4(116):116ra6. PMID: 22238334.
      View in: PubMed
    163. Cohen AD, Rabinovici GD, Mathis CA, Jagust W, Klunk WE, Ikonomovic MD. Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta. Adv Pharmacol. 2012; 64:27-81. PMID: 22840744; PMCID: PMC3542972.
    164. Reiman EM, Jagust W. Brain imaging in the study of Alzheimer's disease. Neuroimage. 2012 Jun; 61(2):505-16. PMID: 22173295; PMCID: PMC3351556.
    165. Reed BR, Marchant NL, Jagust W, DeCarli CC, Mack W, Chui HC. Coronary risk correlates with cerebral amyloid deposition. Neurobiol Aging. 2012 Sep; 33(9):1979-87. PMID: 22078485; PMCID: PMC3371309.
    166. Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Liu E, Morris JC, Petersen RC, Saykin AJ, Schmidt ME, Shaw L, Siuciak JA, Soares H, Toga AW, Trojanowski JQ. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement. 2012 Feb; 8(1 Suppl):S1-68. PMID: 22047634; PMCID: PMC3329969.
    167. Marchant NL, Reed BR, DeCarli CS, Madison CM, Weiner MW, Chui HC, Jagust W. Cerebrovascular disease, ß-amyloid, and cognition in aging. Neurobiol Aging. 2012 May; 33(5):1006.e25-36. PMID: 22048124; PMCID: PMC3274647.
    168. Ewers M, Insel P, Jagust W, Shaw L, Trojanowski JQ, Aisen P, Petersen RC, Schuff N, Weiner MW. CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects. Cereb Cortex. 2012 Sep; 22(9):1993-2004. PMID: 22038908; PMCID: PMC3500862.
    169. Jagust W, Mormino EC. Lifespan brain activity, ß-amyloid, and Alzheimer's disease. Trends Cogn Sci. 2011 Nov; 15(11):520-6. PMID: 21983147; PMCID: PMC3206968.
    170. Mormino EC, Brandel MG, Madison CM, Marks S, Baker SL, Jagust W. Aß Deposition in aging is associated with increases in brain activation during successful memory encoding. Cereb Cortex. 2012 Aug; 22(8):1813-23. PMID: 21945849; PMCID: PMC3388896.
    171. Chiang GC, Insel PS, Tosun D, Schuff N, Truran-Sacrey D, Raptentsetsang ST, Thompson PM, Reiman EM, Jack CR, Fox NC, Jagust W, Harvey DJ, Beckett LA, Gamst A, Aisen PS, Petersen RC, Weiner MW. Impact of apolipoprotein E4-cerebrospinal fluid ß-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment. Alzheimers Dement. 2011 Sep; 7(5):514-20. PMID: 21889115.
      View in: PubMed
    172. Mormino EC, Brandel MG, Madison CM, Rabinovici GD, Marks S, Baker SL, Jagust W. Not quite PIB-positive, not quite PIB-negative: slight PIB elevations in elderly normal control subjects are biologically relevant. Neuroimage. 2012 Jan 16; 59(2):1152-60. PMID: 21884802; PMCID: PMC3230690.
    173. Toledo JB, Vanderstichele H, Figurski M, Aisen PS, Petersen RC, Weiner MW, Jack CR, Jagust W, Decarli C, Toga AW, Toledo E, Xie SX, Lee VM, Trojanowski JQ, Shaw LM. Factors affecting Aß plasma levels and their utility as biomarkers in ADNI. Acta Neuropathol. 2011 Oct; 122(4):401-13. PMID: 21805181; PMCID: PMC3299300.
    174. Jagust W. Amyloid imaging: liberal or conservative? Let the data decide. Arch Neurol. 2011 Nov; 68(11):1377-8. PMID: 21747005.
      View in: PubMed
    175. Lo RY, Hubbard AE, Shaw LM, Trojanowski JQ, Petersen RC, Aisen PS, Weiner MW, Jagust W. Longitudinal change of biomarkers in cognitive decline. Arch Neurol. 2011 Oct; 68(10):1257-66. PMID: 21670386.
      View in: PubMed
    176. Frisoni GB, Jagust W. Subcortical vascular dementia exists! Neurology. 2011 Jul 05; 77(1):12-3. PMID: 21593436.
      View in: PubMed
    177. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust W, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011 May; 7(3):270-9. PMID: 21514249; PMCID: PMC3312027.
    178. Klostermann EC, Braskie MN, Landau SM, O'Neil JP, Jagust W. Dopamine and frontostriatal networks in cognitive aging. Neurobiol Aging. 2012 Mar; 33(3):623.e15-24. PMID: 21511369; PMCID: PMC3245323.
    179. Tosun D, Schuff N, Mathis CA, Jagust W, Weiner MW. Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment. Brain. 2011 Apr; 134(Pt 4):1077-88. PMID: 21429865; PMCID: PMC3069703.
    180. Mormino EC, Smiljic A, Hayenga AO, Onami SH, Greicius MD, Rabinovici GD, Janabi M, Baker SL, Yen IV, Madison CM, Miller BL, Jagust W. Relationships between ß-amyloid and functional connectivity in different components of the default mode network in aging. Cereb Cortex. 2011 Oct; 21(10):2399-407. PMID: 21383234; PMCID: PMC3169663.
    181. Chen K, Ayutyanont N, Langbaum JB, Fleisher AS, Reschke C, Lee W, Liu X, Bandy D, Alexander GE, Thompson PM, Shaw L, Trojanowski JQ, Jack CR, Landau SM, Foster NL, Harvey DJ, Weiner MW, Koeppe RA, Jagust W, Reiman EM. Characterizing Alzheimer's disease using a hypometabolic convergence index. Neuroimage. 2011 May 01; 56(1):52-60. PMID: 21276856; PMCID: PMC3066300.
    182. Rostomian AH, Madison C, Rabinovici GD, Jagust W. Early 11C-PIB frames and 18F-FDG PET measures are comparable: a study validated in a cohort of AD and FTLD patients. J Nucl Med. 2011 Feb; 52(2):173-9. PMID: 21233181; PMCID: PMC3166243.
    183. Gabel MJ, Foster NL, Heidebrink JL, Higdon R, Aizenstein HJ, Arnold SE, Barbas NR, Boeve BF, Burke JR, Clark CM, Dekosky ST, Farlow MR, Jagust W, Kawas CH, Koeppe RA, Leverenz JB, Lipton AM, Peskind ER, Turner RS, Womack KB, Zamrini EY. Validation of consensus panel diagnosis in dementia. Arch Neurol. 2010 Dec; 67(12):1506-12. PMID: 21149812; PMCID: PMC3178413.
    184. Womack KB, Diaz-Arrastia R, Aizenstein HJ, Arnold SE, Barbas NR, Boeve BF, Clark CM, DeCarli CS, Jagust W, Leverenz JB, Peskind ER, Turner RS, Zamrini EY, Heidebrink JL, Burke JR, DeKosky ST, Farlow MR, Gabel MJ, Higdon R, Kawas CH, Koeppe RA, Lipton AM, Foster NL. Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors. Arch Neurol. 2011 Mar; 68(3):329-37. PMID: 21059987; PMCID: PMC3058918.
    185. Oh H, Mormino EC, Madison C, Hayenga A, Smiljic A, Jagust W. ß-Amyloid affects frontal and posterior brain networks in normal aging. Neuroimage. 2011 Feb 01; 54(3):1887-95. PMID: 20965254; PMCID: PMC3038633.
    186. Jagust W. Amyloid imaging: coming to a PET scanner near you. Ann Neurol. 2010 Sep; 68(3):277-8. PMID: 20818786.
      View in: PubMed
    187. Wu X, Chen K, Yao L, Ayutyanont N, Langbaum JB, Fleisher A, Reschke C, Lee W, Liu X, Alexander GE, Bandy D, Foster NL, Thompson PM, Harvey DJ, Weiner MW, Koeppe RA, Jagust W, Reiman EM. Assessing the reliability to detect cerebral hypometabolism in probable Alzheimer's disease and amnestic mild cognitive impairment. J Neurosci Methods. 2010 Oct 15; 192(2):277-85. PMID: 20678521; PMCID: PMC2952503.
    188. Braskie MN, Landau SM, Wilcox CE, Taylor SD, O'Neil JP, Baker SL, Madison CM, Jagust W. Correlations of striatal dopamine synthesis with default network deactivations during working memory in younger adults. Hum Brain Mapp. 2011 Jun; 32(6):947-61. PMID: 20578173; PMCID: PMC3176660.
    189. Apostolova LG, Hwang KS, Andrawis JP, Green AE, Babakchanian S, Morra JH, Cummings JL, Toga AW, Trojanowski JQ, Shaw LM, Jack CR, Petersen RC, Aisen PS, Jagust W, Koeppe RA, Mathis CA, Weiner MW, Thompson PM. 3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects. Neurobiol Aging. 2010 Aug; 31(8):1284-303. PMID: 20538372; PMCID: PMC3051831.
    190. Wilcox CE, Braskie MN, Kluth JT, Jagust W. Overeating Behavior and Striatal Dopamine with 6-[F]-Fluoro-L-m-Tyrosine PET. J Obes. 2010; 2010. PMID: 20798859; PMCID: PMC2925447.
    191. Weiner MW, Aisen PS, Jack CR, Jagust W, Trojanowski JQ, Shaw L, Saykin AJ, Morris JC, Cairns N, Beckett LA, Toga A, Green R, Walter S, Soares H, Snyder P, Siemers E, Potter W, Cole PE, Schmidt M. The Alzheimer's disease neuroimaging initiative: progress report and future plans. Alzheimers Dement. 2010 May; 6(3):202-11.e7. PMID: 20451868; PMCID: PMC2927112.
    192. Jagust W, Bandy D, Chen K, Foster NL, Landau SM, Mathis CA, Price JC, Reiman EM, Skovronsky D, Koeppe RA. The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core. Alzheimers Dement. 2010 May; 6(3):221-9. PMID: 20451870; PMCID: PMC2920531.
    193. Trojanowski JQ, Vandeerstichele H, Korecka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter WZ, Weiner MW, Jack CR, Jagust W, Toga AW, Lee VM, Shaw LM. Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects. Alzheimers Dement. 2010 May; 6(3):230-8. PMID: 20451871; PMCID: PMC2867838.
    194. Aisen PS, Petersen RC, Donohue MC, Gamst A, Raman R, Thomas RG, Walter S, Trojanowski JQ, Shaw LM, Beckett LA, Jack CR, Jagust W, Toga AW, Saykin AJ, Morris JC, Green RC, Weiner MW. Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans. Alzheimers Dement. 2010 May; 6(3):239-46. PMID: 20451872; PMCID: PMC2867843.
    195. Furst AJ, Rabinovici GD, Rostomian AH, Steed T, Alkalay A, Racine C, Miller BL, Jagust W. Cognition, glucose metabolism and amyloid burden in Alzheimer's disease. Neurobiol Aging. 2012 Feb; 33(2):215-25. PMID: 20417582; PMCID: PMC2920373.
    196. Chen K, Langbaum JB, Fleisher AS, Ayutyanont N, Reschke C, Lee W, Liu X, Bandy D, Alexander GE, Thompson PM, Foster NL, Harvey DJ, de Leon MJ, Koeppe RA, Jagust W, Weiner MW, Reiman EM. Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative. Neuroimage. 2010 Jun; 51(2):654-64. PMID: 20202480; PMCID: PMC2856742.
    197. Lavretsky H, Zheng L, Weiner MW, Mungas D, Reed B, Kramer JH, Jagust W, Chui H, Mack WJ. Association of depressed mood and mortality in older adults with and without cognitive impairment in a prospective naturalistic study. Am J Psychiatry. 2010 May; 167(5):589-97. PMID: 20160005; PMCID: PMC2864365.
    198. Rabinovici GD, Furst AJ, Alkalay A, Racine CA, O'Neil JP, Janabi M, Baker SL, Agarwal N, Bonasera SJ, Mormino EC, Weiner MW, Gorno-Tempini ML, Rosen HJ, Miller BL, Jagust W. Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. Brain. 2010 Feb; 133(Pt 2):512-28. PMID: 20080878; PMCID: PMC2858015.
    199. Jack CR, Knopman DS, Jagust W, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010 Jan; 9(1):119-28. PMID: 20083042; PMCID: PMC2819840.
    200. Kuczynski B, Targan E, Madison C, Weiner M, Zhang Y, Reed B, Chui HC, Jagust W. White matter integrity and cortical metabolic associations in aging and dementia. Alzheimers Dement. 2010 Jan; 6(1):54-62. PMID: 20129319; PMCID: PMC2817977.
    201. Schuff N, Matsumoto S, Kmiecik J, Studholme C, Du A, Ezekiel F, Miller BL, Kramer JH, Jagust W, Chui HC, Weiner MW. Cerebral blood flow in ischemic vascular dementia and Alzheimer's disease, measured by arterial spin-labeling magnetic resonance imaging. Alzheimers Dement. 2009 Nov; 5(6):454-62. PMID: 19896584; PMCID: PMC2802181.
    202. Jagust W. Genes and cognitive aging. Front Neurosci. 2009; 3(2):161-3. PMID: 20228865; PMCID: PMC2752315.
    203. Landau SM, Harvey D, Madison CM, Koeppe RA, Reiman EM, Foster NL, Weiner MW, Jagust W. Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging. 2011 Jul; 32(7):1207-18. PMID: 19660834; PMCID: PMC2891865.
    204. Jagust W. Mapping brain beta-amyloid. Curr Opin Neurol. 2009 Aug; 22(4):356-61. PMID: 19478666; PMCID: PMC2882160.
    205. Jagust W. Amyloid + activation = Alzheimer's? Neuron. 2009 Jul 30; 63(2):141-3. PMID: 19640471.
      View in: PubMed
    206. Barnes DE, Yaffe K, Belfor N, Jagust W, DeCarli C, Reed BR, Kramer JH. Computer-based cognitive training for mild cognitive impairment: results from a pilot randomized, controlled trial. Alzheimer Dis Assoc Disord. 2009 Jul-Sep; 23(3):205-10. PMID: 19812460; PMCID: PMC2760033.
    207. Cools R, Frank MJ, Gibbs SE, Miyakawa A, Jagust W, D'Esposito M. Striatal dopamine predicts outcome-specific reversal learning and its sensitivity to dopaminergic drug administration. J Neurosci. 2009 Feb 04; 29(5):1538-43. PMID: 19193900; PMCID: PMC2940719.
    208. Langbaum JB, Chen K, Lee W, Reschke C, Bandy D, Fleisher AS, Alexander GE, Foster NL, Weiner MW, Koeppe RA, Jagust W, Reiman EM. Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Neuroimage. 2009 May 01; 45(4):1107-16. PMID: 19349228; PMCID: PMC2886795.
    209. Van Boven RW, Harrington GS, Hackney DB, Ebel A, Gauger G, Bremner JD, D'Esposito M, Detre JA, Haacke EM, Jack CR, Jagust W, Le Bihan D, Mathis CA, Mueller S, Mukherjee P, Schuff N, Chen A, Weiner MW. Advances in neuroimaging of traumatic brain injury and posttraumatic stress disorder. J Rehabil Res Dev. 2009; 46(6):717-57. PMID: 20104401; PMCID: PMC3233771.
    210. Braskie MN, Wilcox CE, Landau SM, O'Neil JP, Baker SL, Madison CM, Kluth JT, Jagust W. Relationship of striatal dopamine synthesis capacity to age and cognition. J Neurosci. 2008 Dec 24; 28(52):14320-8. PMID: 19109513; PMCID: PMC2880923.
    211. Lavretsky H, Zheng L, Weiner MW, Mungas D, Reed B, Kramer JH, Jagust W, Chui H, Mack WJ. The MRI brain correlates of depressed mood, anhedonia, apathy, and anergia in older adults with and without cognitive impairment or dementia. Int J Geriatr Psychiatry. 2008 Oct; 23(10):1040-50. PMID: 18412291; PMCID: PMC2575050.
    212. Rabinovici GD, Jagust W, Furst AJ, Ogar JM, Racine CA, Mormino EC, O'Neil JP, Lal RA, Dronkers NF, Miller BL, Gorno-Tempini ML. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol. 2008 Oct; 64(4):388-401. PMID: 18991338; PMCID: PMC2648510.
    213. DeCarli C, Reed BR, Jagust W, Martinez O, Ortega M, Mungas D. Brain behavior relationships among African Americans, whites, and Hispanics. Alzheimer Dis Assoc Disord. 2008 Oct-Dec; 22(4):382-91. PMID: 19068502; PMCID: PMC2743876.
    214. Farias ST, Mungas D, Reed BR, Cahn-Weiner D, Jagust W, Baynes K, Decarli C. The measurement of everyday cognition (ECog): scale development and psychometric properties. Neuropsychology. 2008 Jul; 22(4):531-44. PMID: 18590364; PMCID: PMC2877034.
    215. Landau SM, Lal R, O'Neil JP, Baker S, Jagust W. Striatal dopamine and working memory. Cereb Cortex. 2009 Feb; 19(2):445-54. PMID: 18550595; PMCID: PMC2733326.
    216. Kuczynski B, Reed B, Mungas D, Weiner M, Chui HC, Jagust W. Cognitive and anatomic contributions of metabolic decline in Alzheimer disease and cerebrovascular disease. Arch Neurol. 2008 May; 65(5):650-5. PMID: 18474742; PMCID: PMC2556212.
    217. Garrod MG, Green R, Allen LH, Mungas DM, Jagust W, Haan MN, Miller JW. Fraction of total plasma vitamin B12 bound to transcobalamin correlates with cognitive function in elderly Latinos with depressive symptoms. Clin Chem. 2008 Jul; 54(7):1210-7. PMID: 18451312; PMCID: PMC2752269.
    218. Eberling JL, Bankiewicz KS, O'Neil JP, Jagust W. PET 6-[F]fluoro-L-m-tyrosine Studies of Dopaminergic Function in Human and Nonhuman Primates. Front Hum Neurosci. 2007; 1:9. PMID: 18958223; PMCID: PMC2525990.
    219. Jagust W. Is amnestic mild cognitive impairment always AD? Neurology. 2008 Feb 12; 70(7):502-3. PMID: 18268243.
      View in: PubMed
    220. Cools R, Gibbs SE, Miyakawa A, Jagust W, D'Esposito M. Working memory capacity predicts dopamine synthesis capacity in the human striatum. J Neurosci. 2008 Jan 30; 28(5):1208-12. PMID: 18234898.
      View in: PubMed
    221. Jagust W, Zheng L, Harvey DJ, Mack WJ, Vinters HV, Weiner MW, Ellis WG, Zarow C, Mungas D, Reed BR, Kramer JH, Schuff N, DeCarli C, Chui HC. Neuropathological basis of magnetic resonance images in aging and dementia. Ann Neurol. 2008 Jan; 63(1):72-80. PMID: 18157909; PMCID: PMC2624571.
    222. Foster NL, Heidebrink JL, Clark CM, Jagust W, Arnold SE, Barbas NR, DeCarli CS, Turner RS, Koeppe RA, Higdon R, Minoshima S. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain. 2007 Oct; 130(Pt 10):2616-35. PMID: 17704526.
      View in: PubMed
    223. Haan MN, Aiello AE, West NA, Jagust W. C-reactive protein and rate of dementia in carriers and non carriers of Apolipoprotein APOE4 genotype. Neurobiol Aging. 2008 Dec; 29(12):1774-82. PMID: 17540481; PMCID: PMC2593150.
    224. Jagust W. What can imaging reveal about obesity and the brain? Curr Alzheimer Res. 2007 Apr; 4(2):135-9. PMID: 17430236.
      View in: PubMed
    225. Haan MN, Miller JW, Aiello AE, Whitmer RA, Jagust W, Mungas DM, Allen LH, Green R. Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging. Am J Clin Nutr. 2007 Feb; 85(2):511-7. PMID: 17284751.
      View in: PubMed
    226. Reed BR, Mungas DM, Kramer JH, Ellis W, Vinters HV, Zarow C, Jagust W, Chui HC. Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease. Brain. 2007 Mar; 130(Pt 3):731-9. PMID: 17267522.
      View in: PubMed
    227. Chui HC, Zarow C, Mack WJ, Ellis WG, Zheng L, Jagust W, Mungas D, Reed BR, Kramer JH, Decarli CC, Weiner MW, Vinters HV. Cognitive impact of subcortical vascular and Alzheimer's disease pathology. Ann Neurol. 2006 Dec; 60(6):677-87. PMID: 17192928; PMCID: PMC1851933.
    228. Sun FT, Schriber RA, Greenia JM, He J, Gitcho A, Jagust W. Automated template-based PET region of interest analyses in the aging brain. Neuroimage. 2007 Jan 15; 34(2):608-17. PMID: 17112749; PMCID: PMC1828371.
    229. Aiello AE, Haan M, Blythe L, Moore K, Gonzalez JM, Jagust W. The influence of latent viral infection on rate of cognitive decline over 4 years. J Am Geriatr Soc. 2006 Jul; 54(7):1046-54. PMID: 16866674.
      View in: PubMed
    230. Zhu X, Schuff N, Kornak J, Soher B, Yaffe K, Kramer JH, Ezekiel F, Miller BL, Jagust W, Weiner MW. Effects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imaging. Alzheimer Dis Assoc Disord. 2006 Apr-Jun; 20(2):77-85. PMID: 16772742; PMCID: PMC1820860.
    231. Jagust W, Gitcho A, Sun F, Kuczynski B, Mungas D, Haan M. Brain imaging evidence of preclinical Alzheimer's disease in normal aging. Ann Neurol. 2006 Apr; 59(4):673-81. PMID: 16470518.
      View in: PubMed
    232. Nordahl CW, Ranganath C, Yonelinas AP, Decarli C, Fletcher E, Jagust W. White matter changes compromise prefrontal cortex function in healthy elderly individuals. J Cogn Neurosci. 2006 Mar; 18(3):418-29. PMID: 16513006; PMCID: PMC3776596.
    233. Jagust W. Positron emission tomography and magnetic resonance imaging in the diagnosis and prediction of dementia. Alzheimers Dement. 2006 Jan; 2(1):36-42. PMID: 19595854.
      View in: PubMed
    234. Kishiyama MM, Yonelinas AP, Kroll NE, Lazzara MM, Nolan EC, Jones EG, Jagust W. Bilateral thalamic lesions affect recollection- and familiarity-based recognition memory judgments. Cortex. 2005 Dec; 41(6):778-88. PMID: 16353367.
      View in: PubMed
    235. Ramos MI, Allen LH, Mungas DM, Jagust W, Haan MN, Green R, Miller JW. Low folate status is associated with impaired cognitive function and dementia in the Sacramento Area Latino Study on Aging. Am J Clin Nutr. 2005 Dec; 82(6):1346-52. PMID: 16332669.
      View in: PubMed
    236. Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack C, Jagust W, Trojanowski JQ, Toga AW, Beckett L. The Alzheimer's disease neuroimaging initiative. Neuroimaging Clin N Am. 2005 Nov; 15(4):869-77, xi-xii. PMID: 16443497; PMCID: PMC2376747.
    237. Jagust W, Harvey D, Mungas D, Haan M. Central obesity and the aging brain. Arch Neurol. 2005 Oct; 62(10):1545-8. PMID: 16216937.
      View in: PubMed
    238. Farias ST, Mungas D, Jagust W. Degree of discrepancy between self and other-reported everyday functioning by cognitive status: dementia, mild cognitive impairment, and healthy elders. Int J Geriatr Psychiatry. 2005 Sep; 20(9):827-34. PMID: 16116577; PMCID: PMC2872134.
    239. Newman AB, Fitzpatrick AL, Lopez O, Jackson S, Lyketsos C, Jagust W, Ives D, Dekosky ST, Kuller LH. Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. J Am Geriatr Soc. 2005 Jul; 53(7):1101-7. PMID: 16108925.
      View in: PubMed
    240. Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack CR, Jagust W, Trojanowski JQ, Toga AW, Beckett L. Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers Dement. 2005 Jul; 1(1):55-66. PMID: 17476317.
      View in: PubMed
    241. Du AT, Schuff N, Chao LL, Kornak J, Jagust W, Kramer JH, Reed BR, Miller BL, Norman D, Chui HC, Weiner MW. Age effects on atrophy rates of entorhinal cortex and hippocampus. Neurobiol Aging. 2006 May; 27(5):733-40. PMID: 15961190; PMCID: PMC1779763.
    242. Du AT, Schuff N, Chao LL, Kornak J, Ezekiel F, Jagust W, Kramer JH, Reed BR, Miller BL, Norman D, Chui HC, Weiner MW. White matter lesions are associated with cortical atrophy more than entorhinal and hippocampal atrophy. Neurobiol Aging. 2005 Apr; 26(4):553-9. PMID: 15653183.
      View in: PubMed
    243. Johnson NA, Jahng GH, Weiner MW, Miller BL, Chui HC, Jagust W, Gorno-Tempini ML, Schuff N. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology. 2005 Mar; 234(3):851-9. PMID: 15734937; PMCID: PMC1851934.
    244. Nordahl CW, Ranganath C, Yonelinas AP, DeCarli C, Reed BR, Jagust W. Different mechanisms of episodic memory failure in mild cognitive impairment. Neuropsychologia. 2005; 43(11):1688-97. PMID: 16009250; PMCID: PMC3771323.
    245. Jagust W. Dementia: finding the signals in the noise. Lancet Neurol. 2005 Jan; 4(1):10-1. PMID: 15620851.
      View in: PubMed
    246. Fitzpatrick AL, Kuller LH, Lopez OL, Kawas CH, Jagust W. Survival following dementia onset: Alzheimer's disease and vascular dementia. J Neurol Sci. 2005 Mar 15; 229-230:43-9. PMID: 15760618.
      View in: PubMed
    247. DeCarli C, Fletcher E, Ramey V, Harvey D, Jagust W. Anatomical mapping of white matter hyperintensities (WMH): exploring the relationships between periventricular WMH, deep WMH, and total WMH burden. Stroke. 2005 Jan; 36(1):50-5. PMID: 15576652; PMCID: PMC3816357.
    248. Ezekiel F, Chao L, Kornak J, Du AT, Cardenas V, Truran D, Jagust W, Chui H, Miller B, Yaffe K, Schuff N, Weiner M. Comparisons between global and focal brain atrophy rates in normal aging and Alzheimer disease: Boundary Shift Integral versus tracing of the entorhinal cortex and hippocampus. Alzheimer Dis Assoc Disord. 2004 Oct-Dec; 18(4):196-201. PMID: 15592130; PMCID: PMC1820853.
    249. Reed BR, Eberling JL, Mungas D, Weiner M, Kramer JH, Jagust W. Effects of white matter lesions and lacunes on cortical function. Arch Neurol. 2004 Oct; 61(10):1545-50. PMID: 15477508.
      View in: PubMed
    250. Kramer JH, Schuff N, Reed BR, Mungas D, Du AT, Rosen HJ, Jagust W, Miller BL, Weiner MW, Chui HC. Hippocampal volume and retention in Alzheimer's disease. J Int Neuropsychol Soc. 2004 Jul; 10(4):639-43. PMID: 15327742; PMCID: PMC1820856.
    251. Farias ST, Mungas D, Reed B, Haan MN, Jagust W. Everyday functioning in relation to cognitive functioning and neuroimaging in community-dwelling Hispanic and non-Hispanic older adults. J Int Neuropsychol Soc. 2004 May; 10(3):342-54. PMID: 15147592; PMCID: PMC2872145.
    252. Petkov CI, Wu CC, Eberling JL, Mungas D, Zrelak PA, Yonelinas AP, Haan MN, Jagust W. Correlates of memory function in community-dwelling elderly: the importance of white matter hyperintensities. J Int Neuropsychol Soc. 2004 May; 10(3):371-81. PMID: 15147595.
      View in: PubMed
    253. Jagust W. Molecular neuroimaging in Alzheimer's disease. NeuroRx. 2004 Apr; 1(2):206-12. PMID: 15717021.
      View in: PubMed
    254. Maltz JS, Eberling JL, Jagust W, Budinger TF. Enhanced cutaneous vascular response in AD subjects under donepezil therapy. Neurobiol Aging. 2004 Apr; 25(4):475-81. PMID: 15013568.
      View in: PubMed
    255. Jagust W. The proteomics of positron emission tomography. Ann Neurol. 2004 Mar; 55(3):303-5. PMID: 14991807.
      View in: PubMed
    256. Reed BR, Mungas DM, Kramer JH, Betz BP, Ellis W, Vinters HV, Zarow C, Jagust W, Chui HC. Clinical and neuropsychological features in autopsy-defined vascular dementia. Clin Neuropsychol. 2004 Feb; 18(1):63-74. PMID: 15595359.
      View in: PubMed
    257. Fitzpatrick AL, Kuller LH, Ives DG, Lopez OL, Jagust W, Breitner JC, Jones B, Lyketsos C, Dulberg C. Incidence and prevalence of dementia in the Cardiovascular Health Study. J Am Geriatr Soc. 2004 Feb; 52(2):195-204. PMID: 14728627.
      View in: PubMed
    258. Higdon R, Foster NL, Koeppe RA, DeCarli CS, Jagust W, Clark CM, Barbas NR, Arnold SE, Turner RS, Heidebrink JL, Minoshima S. A comparison of classification methods for differentiating fronto-temporal dementia from Alzheimer's disease using FDG-PET imaging. Stat Med. 2004 Jan 30; 23(2):315-26. PMID: 14716732.
      View in: PubMed
    259. Eberling JL, Wu C, Tong-Turnbeaugh R, Jagust W. Estrogen- and tamoxifen-associated effects on brain structure and function. Neuroimage. 2004 Jan; 21(1):364-71. PMID: 14741674.
      View in: PubMed
    260. Lopez OL, Jagust W, Dulberg C, Becker JT, DeKosky ST, Fitzpatrick A, Breitner J, Lyketsos C, Jones B, Kawas C, Carlson M, Kuller LH. Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2. Arch Neurol. 2003 Oct; 60(10):1394-9. PMID: 14568809.
      View in: PubMed
    261. Lopez OL, Jagust W, DeKosky ST, Becker JT, Fitzpatrick A, Dulberg C, Breitner J, Lyketsos C, Jones B, Kawas C, Carlson M, Kuller LH. Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Arch Neurol. 2003 Oct; 60(10):1385-9. PMID: 14568808.
      View in: PubMed
    262. Miller JW, Green R, Ramos MI, Allen LH, Mungas DM, Jagust W, Haan MN. Homocysteine and cognitive function in the Sacramento Area Latino Study on Aging. Am J Clin Nutr. 2003 Sep; 78(3):441-7. PMID: 12936927.
      View in: PubMed
    263. Aisen PS, Egelko S, Andrews H, Diaz-Arrastia R, Weiner M, DeCarli C, Jagust W, Miller JW, Green R, Bell K, Sano M. A pilot study of vitamins to lower plasma homocysteine levels in Alzheimer disease. Am J Geriatr Psychiatry. 2003 Mar-Apr; 11(2):246-9. PMID: 12611755.
      View in: PubMed
    264. Haan MN, Mungas DM, Gonzalez HM, Ortiz TA, Acharya A, Jagust W. Prevalence of dementia in older latinos: the influence of type 2 diabetes mellitus, stroke and genetic factors. J Am Geriatr Soc. 2003 Feb; 51(2):169-77. PMID: 12558712.
      View in: PubMed
    265. Wu CC, Mungas D, Eberling JL, Reed BR, Jagust W. Imaging Interactions between Alzheimer's disease and cerebrovascular disease. Ann N Y Acad Sci. 2002 Nov; 977:403-10. PMID: 12480779.
      View in: PubMed
    266. Jagust W, Eberling JL, Wu CC, Finkbeiner A, Mungas D, Valk PE, Haan MN. Brain function and cognition in a community sample of elderly Latinos. Neurology. 2002 Aug 13; 59(3):378-83. PMID: 12177371.
      View in: PubMed
    267. Haan MN, Jagust W, Galasko D, Kaye J. Effect of extrapyramidal signs and Lewy bodies on survival in patients with Alzheimer disease. Arch Neurol. 2002 Apr; 59(4):588-93. PMID: 11939893.
      View in: PubMed
    268. Hsu YY, Schuff N, Amend DL, Du AT, Norman D, Chui HC, Jagust W, Weiner MW. Quantitative magnetic resonance imaging differences between Alzheimer disease with and without subcortical lacunes. Alzheimer Dis Assoc Disord. 2002 Apr-Jun; 16(2):58-64. PMID: 12040300; PMCID: PMC1820852.
    269. Jagust W, Eberling JL, Reed BR, Mathis CA, Budinger TF. Clinical studies of cerebral blood flow in Alzheimer's disease. Ann N Y Acad Sci. 1997 Sep 26; 826:254-62. PMID: 9329697.
      View in: PubMed
    William's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _

    This site is running Profiles RNS version v2.10.1-548-g4cb907d4 on PROFILES-PWEB02.